Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: The endoscopic management of primary sclerosing cholangitis (PSC)-associated dominant strictures remainschallenging. This systematic review and meta-analysis aimed to compare balloon dilation and stent placement in the treatment ofdominant strictures among PSC patients. Methods: Literature searches on MEDLINE, EMBASE, Cochrane CENTRAL and Lilacs/Bireme were performed for studiespublished until December 2020. Measured outcomes included clinical efficacy, stricture recurrence, cumulative recurrencefree rate,transplant rate, 5-year survival rate, and adverse events (i.e., pancreatitis, cholangitis, bleeding, perforation and death). Results: A total of 5 studies (n=467) were included. Based on pooled analyses, there were no differences in clinical efficacy (riskdifference [RD], -0.13; 95% confidence interval [CI], -0.58 to 0.33; I2=93%) or transplant rates (RD, -0.09; 95% CI, -0.19 to 0.01;I2=0%); however, the risk of occurrence of adverse events was lower with balloon dilatation than with stent placement (RD,-0.34; 95% CI, -0.45 to -0.23; I2=61%). Among the types of adverse events reported, only the rates of cholangitis/bacteremia weresignificantly lower in balloon dilation patients (RD, -0.19; 95% CI, -0.25 to -0.13; I2=51%). Conclusions: Compared to balloon dilation, stent placement for dominant strictures in PSC appeared to have higher complicationrates without significant differences in efficacy.
Abstract
Background/Aims: The endoscopic management of primary sclerosing cholangitis (PSC)-associated dominant strictures remainschallenging. This systematic review and meta-analysis aimed to compare balloon dilation and stent placement in the treatment ofdominant strictures among PSC patients. Methods: Literature searches on MEDLINE, EMBASE, Cochrane CENTRAL and Lilacs/Bireme were performed for studiespublished until December 2020. Measured outcomes included clinical efficacy, stricture recurrence, cumulative recurrencefree rate,transplant rate, 5-year survival rate, and adverse events (i.e., pancreatitis, cholangitis, bleeding, perforation and death). Results: A total of 5 studies (n=467) were included. Based on pooled analyses, there were no differences in clinical efficacy (riskdifference [RD], -0.13; 95% confidence interval [CI], -0.58 to 0.33; I2=93%) or transplant rates (RD, -0.09; 95% CI, -0.19 to 0.01;I2=0%); however, the risk of occurrence of adverse events was lower with balloon dilatation than with stent placement (RD,-0.34; 95% CI, -0.45 to -0.23; I2=61%). Among the types of adverse events reported, only the rates of cholangitis/bacteremia weresignificantly lower in balloon dilation patients (RD, -0.19; 95% CI, -0.25 to -0.13; I2=51%). Conclusions: Compared to balloon dilation, stent placement for dominant strictures in PSC appeared to have higher complicationrates without significant differences in efficacy.
참고문헌 (39)
- Lee YM, "Primary sclerosing cholangitis", N Engl J Med, 332, pp.924~933 (1995)
- Angulo P, "Primary sclerosing cholangitis", Hepatology, 30, pp.325~332 (1999)
- Njei B, "Systematic review with meta-analysis : endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis", Aliment Pharmacol Ther, 44, pp.1139~1151 (2016)
- Tabibian JH, "Endoscopic management of primary sclerosing cholangitis", Expert Rev Gastroenterol Hepatol, 12, pp.693~703 (2018)
- Broomé U, "Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis", Gut, 38, pp.610~615 (1996)
- Sclair SN, "Current concepts in primary biliary cirrhosis and primary sclerosing cholangitis", Clin Transl Gastroenterol, 6, pp.e109~ (2015)
- Sedki M, "Update in the care and management of patients with primary sclerosing cholangitis", Curr Gastroenterol Rep, 20, pp.29~ (2018)
- Karlsen TH, "Primary sclerosing cholangitis-a comprehensive review", J Hepatol, 67, pp.1298~1323 (2017)
- Weismüller TJ, "Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis", Gastroenterology, 152, pp.1975~1984 (2017)
- Diogo Turiani Hourneax de Moura, "Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography-Based Tissue Sampling in Suspected Malignant Biliary Strictures: A Meta-Analysis of Same-Session Procedures", Clinical Endoscopy, 53(4), pp.417~428 (2020), 대한소화기내시경학회[DOI]
- Abu-Wasel B, "Biliary stent therapy for dominant strictures in patients affected by primary sclerosing cholangitis", Pathobiology, 80, pp.182~193 (2013)
- Moura DTH, "EUS-FNA versus ERCP for tissue diagnosis of suspect malignant biliary strictures : a prospective comparative study", Endosc Int Open, 6, pp.E769~E777 (2018)
- de Oliveira PVAG, "Efficacy of digital single-operator cholangioscopy in the visual interpretation of indeterminate biliary strictures : a systematic review and meta-analysis", Surg Endosc, 34, pp.3321~3329 (2020)
- Delgado AA de A, "Propofol vs traditional sedatives for sedation in endoscopy : a systematic review and meta-analysis", World J Gastrointest Endosc, 11, pp.573~588 (2019)
- Matsubayashi CO, "Is endoscopic balloon dilation still associated with higher rates of pancreatitis? : a systematic review and meta-analysis", Pancreas, 49, pp.158~174 (2020)
- Funari MP, "Adverse events after biliary sphincterotomy: does the electric current mode make a difference? a systematic review and meta-analysis of randomized controlled trials", Clin Res Hepatol Gastroenterol, 44, pp.739~752 (2020)
- Passos ML, "Efficacy and safety of carbon dioxide insufflation versus air insufflation during endoscopic retrograde cholangiopancreatography in randomized controlled trials : a systematic review and meta-analysis", Endosc Int Open, 7, pp.E487~E497 (2019)
- Serrano JPR, "Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis : a systematic review and meta-analysis", Endosc Int Open, 7, pp.E477~E486 (2019)
- European Society of Gastrointestinal Endoscopy, "Role of endoscopy in primary sclerosing cholangitis:european society of gastrointestinal endoscopy (ESGE) and european association for the study of the liver (EASL) clinical guideline", J Hepatol, 66, pp.1265~1281 (2017)
- Chapman MH, "British society of gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis", Gut, 68, pp.1356~1378 (2019)
- Logiudice FP, "Endoscopic ultrasound-guided vs endoscopic retrograde cholangiopancreatography biliary drainage for obstructed distal malignant biliary strictures : a systematic review and meta-analysis", World J Gastrointest Endosc, 11, pp.281~291 (2019)
- Parsi MA, "Common controversies in management of biliary strictures", World J Gastroenterol, 23, pp.1119~1124 (2017)
- Modha K, "Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist", World J Hepatol, 7, pp.799~805 (2015)
- Ponsioen CY, "No superiority of stents vs balloon dilatation for dominant strictures in patients with primary sclerosing cholangitis", Gastroenterology, 155, pp.752~759 (2018)
- Costamagna G, "Current treatment of benign biliary strictures", Ann Gastroenterol, 26, pp.37~40 (2013)
- De Moura DTH, "Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture : systematic review and meta-analysis", Endosc Ultrasound, 7, pp.10~19 (2018)
- Visconti TA de C, "Metallic vs plastic stents to treat biliary stricture after liver transplantation : a systematic review and meta-analysis based on randomized trials", Endosc Int Open, 6, pp.E914~E923 (2018)
- Ferreira R, "Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures : what’s new?", World J Gastrointest Endosc, 8, pp.220~231 (2016)
- Kaya M, "Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis", Am J Gastroenterol, 96, pp.1059~1066 (2001)
- Baron TH, "Endoscopic management of benign bile duct strictures", Gastrointest Endosc Clin N Am, 23, pp.295~311 (2013)
- Moher D, "Preferred reporting items for systematic review and meta-analysis protocols(PRISMA-P)2015 statement", Syst Rev, 4, pp.1~ (2015)
- Sterne JAC, "RoB 2: a revised tool for assessing risk of bias in randomised trials", BMJ, 366, pp.l4898~ (2019)
- Sterne JA, "ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions", BMJ, 355, pp.i4919~ (2016)
- Morgan RL, "Development of rapid guidelines : 3. GIN-Mcmaster guideline development checklist extension for rapid recommendations", Health Res Policy Syst, 16, pp.63~ (2018)
- Hozo SP, "Estimating the mean and variance from the median, range, and the size of a sample", BMC Med Res Methodol, 5, pp.13~ (2005)
- Navaneethan U, "Su1646 endoscopic treatment of dominant biliary strictures in primary sclerosing cholangitis patients : comparison of adverse events associated with balloon dilation with and without stenting", Gastrointestinal Endoscopy, 81, pp.AB364~ (2015)
- Al-Lehibi AH, "T1572 : experience with endoscopic therapy in patients with primary sclerosing cholangitis", Gastrointestinal Endoscopy, 71, pp.AB312~ (2010)
- Han S, "Tu1435 ERCP with balloon dilation alone or balloon dilation with stenting for dominant strictures in patients with primary sclerosing cholangitis", Gastrointestinal Endoscopy, 85, pp.AB625~AB626 (2017)
- Njei B, "Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis", Gastrointestinal Endoscopy, 85, pp.773~781 (2017)